Literature DB >> 34302832

African American Men have Increased Risk of Prostate Cancer Detection Despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.

Hiten D Patel1, Chirag P Doshi2, Elizabeth L Koehne2, Spencer Hart3, Michelle Van Kuiken4, Marcus L Quek2, Robert C Flanigan2, Gopal N Gupta5.   

Abstract

OBJECTIVE: To determine whether the frequency of anterior prostate lesions (APL) on multiparametric magnetic resonance imaging (mpMRI) prior to biopsy differed between African American (AA) and non-AA men and evaluate implications of race and tumor location for prostate cancer (PCa) detection.
METHODS: Patients from the Prospective Loyola University mpMRI (PLUM) Prostate Biopsy Cohort (January 2015-December 2020) without prior diagnosis of PCa were evaluated for APLs by race. Multivariable logistic regression models evaluated predictors of APLs and associations of APLs and race with detection of any PCa (grade group 1+) and clinically significant PCa (csPCa; grade group 2+). Additional stratified and propensity score matched analyses were conducted.
RESULTS: Of 1,239 men included, 190 (15.3%) were AA and 302 (24.4%) had at least one APL with no differences by race on multivariable analysis. While men with APLs were twice as likely to harbor PCa or csPCa, the unadjusted proportion of targeted biopsy-confirmed APL PCa (12.6% vs 12.0%) or csPCa (8.4% vs 8.9%) were similar for AA and non-AA men. AA men had higher risk of prostate cancer on targeted cores (OR 1.66 (95%CI 1.06 - 2.61), P = 0.026) which was independent of lesion location or PI-RADS.
CONCLUSION: AA men were found to have similar rates of APLs on mpMRI to non-AA men indicating access to mpMRI may mitigate some of the historical racial disparity based on lesion location. AA men have increased risk of PCa detection compared to non-AA men independent of anterior location or lesion grade on mpMRI reinforcing the importance of identifying genetic, biologic, and socioeconomic drivers.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34302832     DOI: 10.1016/j.urology.2021.07.005

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

Review 1.  A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer.

Authors:  Jacob W Greenberg; Christopher R Koller; Crystal Casado; Benjamin L Triche; L Spencer Krane
Journal:  Ther Adv Urol       Date:  2022-05-04

2.  Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer.

Authors:  Yongheng Zhou; Wenqiang Qi; Jianfeng Cui; Minglei Zhong; Guangda Lv; Sifeng Qu; Shouzhen Chen; Rongyang Li; Benkang Shi; Yaofeng Zhu
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

3.  Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions.

Authors:  Caleb Natale; Christopher R Koller; Jacob W Greenberg; Joshua Pincus; Louis S Krane
Journal:  Life (Basel)       Date:  2021-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.